Owellen RJ, Hartke CA, Hains FO. Pharmocokinetics and metabolism of Vinblastine in
humans. Cancer Res 1977;37:2597–2602.
Rickert DE, Dingley K, Ubick E, Dix KJ, Molina L. Determination of the tissue
distribution and excretion by accelerator mass spectrometry of the nonadecapeptide
(^14) C-Moli1901 in beagle dogs after inytratracheal installation. Chem-Biol Interact
2005;155:55–61.
Slatter JG, Schaaf LJ, Sams JP, Feenstra KL, Johnson MG, Bombardt PA, Cathcart
KS, Verburg MT, Pearson LK, Compton LD, Miller LL, Baker DS, Pesheck CV,
Lord III RS. Pharmacokinetics, metabolism and excretion of irinotecan (CPT-11)
following I.V. infusion of [14C]CPT-11 in cancer patients. Drug Metab Dispos
2000;28(4):423–433.
Snyder WS. Absorbed Dose Per Unit Cumulated Activity for Selected Radionuclides
and Organs, Nm/mird Pamphlet No.11. Oak Ridge: Oak Ridge National
Laboratory; 1975.
US Food and Drug Administration.21 CFR 361 April 1,1999.
Wafelman AR, Hoefnagel CA, Maesse HJ. Renal excretion of iodine-131 labeledmeta-
iodobenzylguanidine and metabolites after therapeutic doses in patients suffering
from different neural crest-derived tumors. Eur J Nucl Med 1997;24(5):544–552.
Walle T, Walle UK, Kumar GN. Axol metabolism and disposition in cancer patients.
Drug Metab Dispos 1995;23:506–512.
Wang L, Zhang H, Swaminathan A, Xue J, Cheng TC, Wu S, Bonacorsi S, Zhu M,
Swaminathan A, Hunphreys WG. Glucuronidation as a major metabolic pathway of
muraglitazar in humans: metabolite profiles in subjects with and without bile
collection. Drug Metab Dispos 2006;34:427–439.
Weber DA, Eckerman KF, Dillman LT, Ryman JC. MIRD Radionuclide Data and
Decay Schemes. New York: Society of Nuclear Medicine; 1989.
Zhang HY, Zhang DL, Ray K. A software filter to remove interference ions from drugs
metabolites in accurate mass liquid chromatography/mass spectrometric analyses. J
Mass Spectrom 2003;38:1110–1112.
Zhang D, Wang L, Raghavan N, Zhang H, Li W, Cheng PT, Yao M, Zhang L, Zhu M,
Bonacorsi S, Yeola S, Mitroka J, Hariharan N, Hosagrahara V, Chandrasena G,
Shyu WC, Humphreys WG. Comparative metabolism of radiolabeled muraglitazar
in animals and humans by quantitative and qualitative metabolite profiling. Drug
Metab Dispos 2007;35:150–167.
Zhang D, Zhang H, Aranibar N, Hanson R, Huang Y, Cheng PT, Wu S, Bonacorsi S,
Zhu M, Swaminathan A, Humphreys WG. Structural elucidation of human
oxidative metabolites of muraglitazar: use of microbial bioreactors in the
biosynthesis of metabolite standards. Drug Metab Dispos 2006;34:267–280.
604 ADME STUDIES IN ANIMALS AND HUMANS